entertainment -WSS

entertainment

author：knowledge 2025-10-02 00:43:06 - browse：5

Devoted Health sign -- health policy coverage from STAT — Courtesy Devoted Health

Devoted Health has been one of the most prominent health insurance and provider startups of the past decade — founded and overseen by several alumni of former President Barack Obama’s administration.

But it has not turned a profit after five years of selling Medicare Advantage plans to older adults, according to a STAT analysis of Devoted’s financial filings. And Devoted isn’t sharing many details about its progress, either.

Health insurance companies take a while to reach profitability because they need to enroll a lot of people, which then allows them to spread medical costs across a bigger pool. But Devoted’s persistent losses raise questions if it, too, will follow the paths of other younger, troubled insurance startups — like Alignment Healthcare, Bright Health, Clover Health, and Oscar Health — that have promised better care while collectively burning through billions of dollars. Most of those other companies have exited or scaled back their participation in various insurance programs, upending the health coverage of millions of people.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Diagnostic tests are hitting their mathematical limits

hotspot

WSS

Rep. Raul Ruiz on the physician shortage and more

What should King Charles tell the public about his cancer?

BioAge raises $170M for combination therapy with Zepbound

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Flagship Pioneering launches a new biotech in two countries

The Readout: Gilead, Bernie Sanders, and other pharma news

hotspot

entertainment

focus

The high cost of giving birth even with insurance

Key House Republican on health care plans exit from Congress

How to save PrEP access — and even expand it

What we’ve learned from the Aduhelm mess

United colonoscopy coverage change 'may cost lives,' doctors say

J&J to emphasize cancer drugs, stop much of its vaccine research

Medical leaders decry Supreme Court decision on affirmative action

What don’t we know about an Alzheimer’s drug side effect?

Cancer drug shortages should be causing more outrage

Private equity deals in Medicare Advantage declines

knowledge

What don’t we know about an Alzheimer’s drug side effect?

Industry veterans launch new biotech VC with $310M

How to pay for weight loss drugs and save Medicare

Gilead might be held responsible for not developing a drug

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

A disappointing year of Humira biosimilars

focus

explore

hotspot

Wikipedia